Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company was a private limited entity providing business support services not elsewhere classified. It is now dissolved and did not operate as a drug developer or clinical-stage company. Pharma Executive Consulting Limited was incorporated in the United Kingdom on November 2, 2010. Its registered office was at Lynton House, Tavistock Square in London. The company's official SIC code was "82990 – Other business support service activities not elsewhere classified," indicating it provided general business consulting rather than specialized pharmaceutical R&D or healthcare services. The firm was officially dissolved on May 28, 2019 and has no ongoing operations or assets. No evidence suggests that this entity developed drugs or medical products; it does not appear in any major pharma/biotech industry rankings nor does it have an R&D pipeline. There are no public records of clinical programs, therapeutic focus areas, partnerships with pharmaceutical companies, manufacturing capabilities, IPO/acquisition events or notable leadership figures associated with drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharma Executive Consulting.